RCM
WGS icon

Radcliffe Capital Management’s GeneDx Holdings WGS Stock Holding History

Radcliffe Capital Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,182
Closed -$4.44M – 714
2020
Q4 		$4.44M Buy
+12,182
New +$4.24M 0.28% 110

Other funds holding WGS

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Radcliffe Capital Management's WGS Position: Q1 2021 in Review

Radcliffe Capital Management sold out of GeneDx Holdings (WGS) in Q1 2021, closing a stake of 12,182 shares — an estimated $4.44M sold.

Radcliffe Capital Management first reported a position in WGS in Q4 2020 and held it in 1 quarter. The position peaked at $4.44M in Q4 2020. 67 funds tracked by Wall St. Rank hold WGS as of Q1 2021.

  • Radcliffe Capital Management reported no remaining GeneDx Holdings position as of Q1 2021 after selling out during the quarter.
  • Radcliffe Capital Management sold 12,182 GeneDx Holdings shares in Q1 2021, an estimated $4.44M.
  • Radcliffe Capital Management first reported a position in GeneDx Holdings in Q4 2020 and held it in 1 quarter.
  • Radcliffe Capital Management's GeneDx Holdings position peaked at $4.44M in Q4 2020.
  • 67 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2021.

Based on Radcliffe Capital Management's 13F filing for Q1 2021, filed 17 May 2021.